Literature DB >> 26710884

SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6.

J Palomero1, M C Vegliante1, A Eguileor1, M L Rodríguez1, P Balsas1, D Martínez2, E Campo1,2, V Amador1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26710884     DOI： 10.1038/leu.2015.355

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma.

Authors:  Laura Pasqualucci; Anna Migliazza; Katia Basso; Jane Houldsworth; R S K Chaganti; Riccardo Dalla-Favera
Journal:  Blood       Date:  2002-12-19       Impact factor: 22.113

Review 2.  Roles of BCL6 in normal and transformed germinal center B cells.

Authors:  Katia Basso; Riccardo Dalla-Favera
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

3.  A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.

Authors:  Masumichi Saito; Jie Gao; Katia Basso; Yukiko Kitagawa; Paula M Smith; Govind Bhagat; Alessandra Pernis; Laura Pasqualucci; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2007-09       Impact factor: 31.743

4.  Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry.

Authors:  Blanca Espinet; Ana Ferrer; Beatriz Bellosillo; Lara Nonell; Antonio Salar; Concepción Fernández-Rodríguez; Eulàlia Puigdecanet; Javier Gimeno; Mar Garcia-Garcia; Maria Carmen Vela; Elisa Luño; Rosa Collado; José Tomás Navarro; Esmeralda de la Banda; Pau Abrisqueta; Leonor Arenillas; Cristina Serrano; Josep Lloreta; Belén Miñana; Andrea Cerutti; Lourdes Florensa; Alberto Orfao; Ferran Sanz; Francesc Solé; David Dominguez-Sola; Sergio Serrano
Journal:  Clin Cancer Res       Date:  2013-12-18       Impact factor: 12.531

Review 5.  Molecular pathogenesis of mantle cell lymphoma.

Authors:  Pedro Jares; Dolors Colomer; Elias Campo
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

6.  IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome.

Authors:  Sergio B Cogliatti; Francesco Bertoni; Dieter R Zimmermann; Samuel Henz; Tim C Diss; Michele Ghielmini; Ulrico Schmid
Journal:  J Pathol       Date:  2005-07       Impact factor: 7.996

7.  A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.

Authors:  Jenny Orchard; Richard Garand; Zadie Davis; Gavin Babbage; Surinder Sahota; Estella Matutes; Daniel Catovsky; Peter W Thomas; Hervé Avet-Loiseau; David Oscier
Journal:  Blood       Date:  2003-02-27       Impact factor: 22.113

8.  SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.

Authors:  Maria Carmela Vegliante; Jara Palomero; Patricia Pérez-Galán; Gaël Roué; Giancarlo Castellano; Alba Navarro; Guillem Clot; Alexandra Moros; Helena Suárez-Cisneros; Sílvia Beà; Luis Hernández; Anna Enjuanes; Pedro Jares; Neus Villamor; Dolors Colomer; José Ignacio Martín-Subero; Elias Campo; Virginia Amador
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

9.  Aberrant Bcl6 protein expression in mantle cell lymphoma.

Authors:  Francisca I Camacho; Juan F García; Juan C Cigudosa; Manuela Mollejo; Patrocinio Algara; Elena Ruíz-Ballesteros; Pablo Gonzalvo; Paloma Martín; Carlos Pérez-Seoane; Joaquín Sánchez-García; Miguel A Piris
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

10.  Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features.

Authors:  Alba Navarro; Guillem Clot; Cristina Royo; Pedro Jares; Anastasia Hadzidimitriou; Andreas Agathangelidis; Vasilis Bikos; Nikos Darzentas; Theodora Papadaki; Itziar Salaverria; Magda Pinyol; Xavier Puig; Jara Palomero; Maria Carmela Vegliante; Virgina Amador; Alejandra Martinez-Trillos; Lenka Stefancikova; Adrian Wiestner; Wyndham Wilson; Christiane Pott; Maria Jose Calasanz; Nicola Trim; Wendy Erber; Birgitta Sander; German Ott; Andreas Rosenwald; Dolors Colomer; Eva Giné; Reiner Siebert; Armando Lopez-Guillermo; Kostas Stamatopoulos; Sílvia Beà; Elías Campo
Journal:  Cancer Res       Date:  2012-08-20       Impact factor: 12.701
View more
  20 in total

1.  Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma.

Authors:  Jeff D Wang; Samuel G Katz; Elizabeth A Morgan; David T Yang; Xueliang Pan; Mina L Xu
Journal:  Hum Pathol       Date:  2019-08-16       Impact factor: 3.466

2.  Impact of Sox11 over-expression in Ba/F3 cells.

Authors:  Martin Lord; Gustav Arvidsson; Agata M Wasik; Birger Christensson; Anthony P Wright; Alf Grandien; Birgitta Sander
Journal:  Haematologica       Date:  2018-06-28       Impact factor: 9.941

3.  SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma.

Authors:  Wenjuan Yang; Yanying Wang; Zhen Yu; Zengjun Li; Gang An; Wei Liu; Rui Lv; Liping Ma; Shuhua Yi; Lugui Qiu
Journal:  Int J Hematol       Date:  2017-04-20       Impact factor: 2.490

Review 4.  Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.

Authors:  Sílvia Beà; Virginia Amador
Journal:  Curr Oncol Rep       Date:  2017-06       Impact factor: 5.075

5.  miR-145 targets the SOX11 3'UTR to suppress endometrial cancer growth.

Authors:  Lei Chang; Zhongfu Yuan; Huirong Shi; Yangyang Bian; Ruixia Guo
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

Review 6.  Molecular Pathogenesis of Mantle Cell Lymphoma.

Authors:  Alba Navarro; Sílvia Beà; Pedro Jares; Elías Campo
Journal:  Hematol Oncol Clin North Am       Date:  2020-07-22       Impact factor: 3.722

7.  CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.

Authors:  Zhihong Hu; Yi Sun; Ellen J Schlette; Guilin Tang; Shaoying Li; Jie Xu; C Cameron Yin; Ken H Young; Keyur Pravinchandra Patel; Roberto N Miranda; Maitrayee Goswami; Michael Wang; Jeffrey L Jorgensen; L Jeffrey Medeiros; Sa A Wang
Journal:  Mod Pathol       Date:  2017-10-06       Impact factor: 7.842

8.  Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.

Authors:  Ana C Queirós; Renée Beekman; Roser Vilarrasa-Blasi; Martí Duran-Ferrer; Guillem Clot; Angelika Merkel; Emanuele Raineri; Nuria Russiñol; Giancarlo Castellano; Sílvia Beà; Alba Navarro; Marta Kulis; Núria Verdaguer-Dot; Pedro Jares; Anna Enjuanes; María José Calasanz; Anke Bergmann; Inga Vater; Itziar Salaverría; Harmen J G van de Werken; Wyndham H Wilson; Avik Datta; Paul Flicek; Romina Royo; Joost Martens; Eva Giné; Armando Lopez-Guillermo; Hendrik G Stunnenberg; Wolfram Klapper; Christiane Pott; Simon Heath; Ivo G Gut; Reiner Siebert; Elías Campo; José I Martín-Subero
Journal:  Cancer Cell       Date:  2016-11-14       Impact factor: 31.743

9.  SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma.

Authors:  Patricia Balsas; Luis Veloza; Guillem Clot; Marta Sureda-Gómez; Marta-Leonor Rodríguez; Christos Masaoutis; Gerard Frigola; Alba Navarro; Silvia Beà; Ferran Nadeu; Eva Giné; Armando López-Guillermo; Antonio Martínez; Inmaculada Ribera-Cortada; Pablo Engel; Leticia Quintanilla-Martínez; Wolfram Klapper; Elias Campo; Virginia Amador
Journal:  Blood       Date:  2021-12-02       Impact factor: 22.113

10.  SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma.

Authors:  Shashidhar S Jatiani; Stephanie Christie; Violetta V Leshchenko; Rinku Jain; Abhijeet Kapoor; Paola Bisignano; Clement Lee; H Ümit Kaniskan; Donna Edwards; Fanye Meng; Alessandro Laganà; Youssef Youssef; Adrian Wiestner; Lapo Alinari; Jian Jin; Marta Filizola; Aneel K Aggarwal; Samir Parekh
Journal:  Clin Cancer Res       Date:  2021-06-22       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.